Characteristic | Subject group | Group P | Statistically significant |
Patients (n = 207) | 103 | 104 |
|
Period | 2000-2011 | 2000-2011 |
|
Sex Male Female |
81 (78.6%) 22 (21.4%) |
95 (91.3%) 9 (8.7%) |
p < 0.01
|
Age range (mean) | 80 - 93 (83.8) | 75 - 79 (76.7) |
|
Primary tumor sites Larynx Nasopharynx Mesopharynx Hypopharynx Oral cavity Salivary glands Nasal cavity/paranasal sinus Auditory organ |
41 6 17 13 13 6 5 2 |
37 4 17 18 13 4 6 5 | NS |
TNM stage Stage I Stage II Stage III Stage IV |
20 25 18 40 |
24 19 1 47 | NS |
Performance status (PS) PS 0 PS 1 PS 2 PS 3 PS 4 |
45 34 16 5 3 |
60 30 8 5 1 | NS |
Average PS | 0.9 | 0.63 | NS |
Multile primary cancer None One Two Three or more |
62 29 10 2 |
61 33 5 5 | NS |
Comorbidity None One Two Three or more Average |
15 32 26 30 1.85 |
25 37 27 15 1.38 |
p < 0.01
|